Testing effectiveness (Phase 2)Study completedNCT04675931
What this trial is testing
To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria
Who this might be right for
Severe Malaria
Novartis Pharmaceuticals 254